Sensex
81,287.19 profit arw -961.42 (-1.17%)
Nifty
25,178.65 profit arw -317.90 (-1.25%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 12-Feb-2026
Hot Pursuit
12-Feb-2026     14:35

Abbott India Q3 PAT jumps 4% YoY to Rs 376 cr

Profit before tax (PBT) stood at Rs 508.98 crore in Q3 FY26, up 4.38% year on year (YoY).

Total expenses increased 7.20% to Rs 1,284.82 crore in Q3 FY26 as against Rs 1,198.44 crore posted in same quarter last year. The cost of materials consumed stood at Rs 147.31 crore (up 26.88% YoY), employee benefit expense was at Rs 196.07 crore (up 45.58% YoY) and finance cost was at Rs 5.48 crore (up 142.47% YoY) during the period under review.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Shares of Abbott India fell 1.06% to currently trade at Rs 26,609.95 on the BSE.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

81,287.19 -961.42 (-1.17%)

Nifty

25,178.65 -317.90 (-1.25%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,630.55 249.52(0.95%)